Targeting Gut Microbiota to Treat Hypertension: A Systematic Review
While hypertension remains the leading modifiable risk factor for cardiovascular morbidity and mortality, the pathogenesis of essential hypertension remains only partially understood. Recently, microbial dysbiosis has been associated with multiple chronic diseases closely related to hypertension. In...
Main Authors: | Joonatan Palmu, Leo Lahti, Teemu Niiranen |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-01-01
|
Series: | International Journal of Environmental Research and Public Health |
Subjects: | |
Online Access: | https://www.mdpi.com/1660-4601/18/3/1248 |
Similar Items
-
Dietary Sources of High Sodium Intake in Turkey: SALTURK II
by: Yunus Erdem, et al.
Published: (2017-08-01) -
Impact of Gut Microbiome on Hypertensive Patients With Low-Salt Intake: Shika Study Results
by: Satoshi Nagase, et al.
Published: (2020-09-01) -
Inhibition of sodium-proton-exchanger subtype 3-mediated sodium absorption in the gut: A new antihypertensive concept
by: Benedikt Linz, et al.
Published: (2020-08-01) -
Washed Microbiota Transplantation Lowers Blood Pressure in Patients With Hypertension
by: Hao-Jie Zhong, et al.
Published: (2021-08-01) -
The Role of Short-Chain Fatty Acids of Gut Microbiota Origin in Hypertension
by: Yeshun Wu, et al.
Published: (2021-09-01)